Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Früh

Showing results (541-550 of 552) with videos related to

Pageof 56
Sort By:
The Lancet. Respiratory Medicine|April 15, 2017
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trialRafael Rosell, Urania Dafni, Enriqueta Felip, et al.
Science Translational Medicine|March 12, 2025
The pentameric complex is not required for congenital CMV transmission in seronegative rhesus macaquesHsuan-Yuan Wang, Husam Taher, Craig N Kreklywich, et al.
Med (New York, N.Y.)|January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitorsNicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.
Science Advances|July 10, 2024
Monoallelic de novo <i>AJAP1</i> loss-of-function variants disrupt trans-synaptic control of neurotransmitter releaseSimon Früh, Sami Boudkkazi, Peter Koppensteiner, et al.
Plos Pathogens|November 24, 2020
In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genomeHusam Taher, Eisa Mahyari, Craig Kreklywich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJ Mazieres, A Drilon, A Lusque, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint BlockadeNina Wyss, Fiamma Berner, Vincent Walter, et al.
Nature Medicine|January 16, 2018
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccineScott G Hansen, Daniel E Zak, Guangwu Xu, et al.
Nature|July 1, 2026
Identification of cross-stage, cross-species malaria CD8<sup>+</sup> T cell antigensCamila R R Barbosa, Luna B de Lacerda, Paulo J G Bettencourt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global ConsortiumSarah Waliany, Alissa J Cooper, Stephen V Liu, et al.
Pageof 56

Showing results (541-550 of 552) with videos related to

Sort By:
Pageof 56
The Lancet. Respiratory Medicine|April 15, 2017
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trialRafael Rosell, Urania Dafni, Enriqueta Felip, et al.
Science Translational Medicine|March 12, 2025
The pentameric complex is not required for congenital CMV transmission in seronegative rhesus macaquesHsuan-Yuan Wang, Husam Taher, Craig N Kreklywich, et al.
Med (New York, N.Y.)|January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitorsNicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.
Science Advances|July 10, 2024
Monoallelic de novo <i>AJAP1</i> loss-of-function variants disrupt trans-synaptic control of neurotransmitter releaseSimon Früh, Sami Boudkkazi, Peter Koppensteiner, et al.
Plos Pathogens|November 24, 2020
In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genomeHusam Taher, Eisa Mahyari, Craig Kreklywich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJ Mazieres, A Drilon, A Lusque, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint BlockadeNina Wyss, Fiamma Berner, Vincent Walter, et al.
Nature Medicine|January 16, 2018
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccineScott G Hansen, Daniel E Zak, Guangwu Xu, et al.
Nature|July 1, 2026
Identification of cross-stage, cross-species malaria CD8<sup>+</sup> T cell antigensCamila R R Barbosa, Luna B de Lacerda, Paulo J G Bettencourt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global ConsortiumSarah Waliany, Alissa J Cooper, Stephen V Liu, et al.
Pageof 56